magnetically-controlled capsule endoscopy, esophagogastroduodenoscopy, CT scan: Magnetically-controlled capsule endoscopy (MCE) images, esophagogastroduodenoscopy (EGD) images, and CT images for early upper gastrointestinal cancer, precancerous lesions, and precancerous conditions
ESD, biopsy: ESD or biopsy for histopathology results
Study summary
The study is designed to collect magnetically-controlled capsule endoscopy (MCE) images, esophagogastroduodenoscopy (EGD) images, CT images, and histopathology results to establish a database for early upper gastrointestinal cancer, precancerous lesions, and precancerous conditions.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
1. Male or female participants aged ≥ 18 years
2. Patients with early upper gastrointestinal cancer referred for endoscopic submucosal dissection (ESD), or patients with upper gastrointestinal precancerous lesions or precancerous conditions referred for biopsy by esophagogastroduodenoscopy (EGD)
3. Participants who are willing and able to participate in this study, complete all required examinations and follow-up visits, and who have provided written informed consent
Exclusion Criteria:
1. Patients who are not eligible for surgery or who refuse any abdominal surgery in case of capsule retention and endoscopic retrieval failure
2. Patients with cardiac pacemaker or other implanted electromedical devices which could interfere with magnetic resonance
3. Suspected or known intestinal stenosis or other known risk factors for capsule retention
4. Patients with dysphagia
5. Pregnancy
6. Allergy to polymeric materials, latex, simethicone, or pronase
7. Patients plan to undergo magnetic resonance imaging examination before excretion of the capsule
8. Patients with any condition that precludes compliance with the study
Primary outcome measure(s)
Magnetically-controlled capsule endoscopy (MCE) images, esophagogastroduodenoscopy (EGD) images, and CT images — Prior to ESD or biopsy
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.